Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas.
Erkan TopkanUgur SelekAhmet KucukBerrin PehlivanPublished in: Journal of inflammation research (2022)
The present results indicated that pre-C-CRT L-PIV measures were associated with favorable median and long-term PFS and OS results in LA-PAC patients, suggesting that the PIV is a potent and independent novel prognostic biomarker.
Keyphrases
- end stage renal disease
- locally advanced
- ejection fraction
- newly diagnosed
- squamous cell carcinoma
- oxidative stress
- chronic kidney disease
- prognostic factors
- rectal cancer
- peritoneal dialysis
- neoadjuvant chemotherapy
- radiation therapy
- patient reported outcomes
- left ventricular
- anti inflammatory
- open label
- study protocol